Some conditions—like cancer—have a variety of options for treatment. For employers, facilitating the ability for employees to discuss their options with an expert in their condition helps uncover the best way to achieve optimal outcomes. Virtual second opinions in particular also eliminate the travel time associated with seeing a specialist and reduce the cost associated with these visits. 

In recent years, cancer expenditures in the United States have been close to $200 billion annually, and they are expected to grow to $246 billion by 2030. In fact:

• Cancer is now the top driver of employer healthcare costs
• The mean expenditure per person for cancer patients is nearly four times higher ($16,346) than for those without cancer ($4,484)
• Close to 1 in 7 employers (13%) report seeing more late-stage cancers, and more than 2 in 5 (44%) employers anticipate seeing an increase in the future

Download this white paper and learn how ensuring the right treatment decisions for cancer—including through expert second opinions—supports better care and outcomes for employees at reduced costs.